ALK-positive Non-small Cell Lung Cancer

Also known as: ALK Positive Non-small Cell Lung Cancer / ALK-positive NSCLC / ALK-positive Non-small Cell Lung Cancer (NSCLC)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09063Ceritinib1Active Not Recruiting1
DB08865Crizotinib1Completed1
DB14860Ensartinib1Unknown Status1
DB01167Itraconazole1Completed1
DB09035Nivolumab1Active Not Recruiting1
DB01045Rifampicin1Completed1
DB13104X-3961Unknown Status1
DB11363Alectinib1 / 2Terminated1
DB09063Ceritinib2Completed1
DB09063Ceritinib2Terminated1
DB12130Lorlatinib2Recruiting1
DB08865Crizotinib3Unknown Status1
DB11363AlectinibNot AvailableCompleted1
DB12267BrigatinibNot AvailableCompleted1
DB09063CeritinibNot AvailableCompleted1
DB08865CrizotinibNot AvailableCompleted1
DB12130LorlatinibNot AvailableCompleted2